These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
148 related items for PubMed ID: 29533483
1. Cutaneous carcinogenic risk evaluation in 375 patients treated with narrowband-UVB phototherapy: A 15-year experience from our Institute. Raone B, Patrizi A, Gurioli C, Gazzola A, Ravaioli GM. Photodermatol Photoimmunol Photomed; 2018 Sep; 34(5):302-306. PubMed ID: 29533483 [Abstract] [Full Text] [Related]
2. Incidence of skin cancers in 3867 patients treated with narrow-band ultraviolet B phototherapy. Hearn RM, Kerr AC, Rahim KF, Ferguson J, Dawe RS. Br J Dermatol; 2008 Sep; 159(4):931-5. PubMed ID: 18834483 [Abstract] [Full Text] [Related]
3. Carcinogenic risks of psoralen UV-A therapy and narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review. Archier E, Devaux S, Castela E, Gallini A, Aubin F, Le Maître M, Aractingi S, Bachelez H, Cribier B, Joly P, Jullien D, Misery L, Paul C, Ortonne JP, Richard MA. J Eur Acad Dermatol Venereol; 2012 May; 26 Suppl 3():22-31. PubMed ID: 22512677 [Abstract] [Full Text] [Related]
4. Melanoma and non-melanoma skin cancer in psoriatic patients treated with high-dose phototherapy. Maiorino A, De Simone C, Perino F, Caldarola G, Peris K. J Dermatolog Treat; 2016 Oct; 27(5):443-7. PubMed ID: 26822468 [Abstract] [Full Text] [Related]
5. The challenge of follow-up in narrowband ultraviolet B phototherapy. Diffey BL, Farr PM. Br J Dermatol; 2007 Aug; 157(2):344-9. PubMed ID: 17553037 [Abstract] [Full Text] [Related]
6. A cross-sectional analysis of skin cancer risk in patients receiving narrow-band ultraviolet B phototherapy: an evaluation of 100 patients. Karaosmanoglu N, Ozdemir Cetinkaya P, Kutlu O, Karaaslan E, Imren IG, Kiratli Nalbant E, Eksioglu M. Arch Dermatol Res; 2020 May; 312(4):249-253. PubMed ID: 31729594 [Abstract] [Full Text] [Related]
7. Frequency of skin cancer among psoriasis, vitiligo, and mycosis fungoides patients treated with narrowband ultraviolet B phototherapy. Mimouni I, Shulman J, Unes AA, Pavlovsky L, Pavlotsky F. Photodermatol Photoimmunol Photomed; 2024 Jan; 40(1):e12936. PubMed ID: 38059681 [Abstract] [Full Text] [Related]
8. No evidence for increased skin cancer risk in psoriasis patients treated with broadband or narrowband UVB phototherapy: a first retrospective study. Weischer M, Blum A, Eberhard F, Röcken M, Berneburg M. Acta Derm Venereol; 2004 Jan; 84(5):370-4. PubMed ID: 15370703 [Abstract] [Full Text] [Related]
9. Risk of skin cancer in psoriasis patients receiving long-term narrowband ultraviolet phototherapy: Results from a Taiwanese population-based cohort study. Lin TL, Wu CY, Chang YT, Juan CK, Chen CC, Yu SH, Chen YJ. Photodermatol Photoimmunol Photomed; 2019 May; 35(3):164-171. PubMed ID: 30536640 [Abstract] [Full Text] [Related]
10. Incidence of skin malignancies in patients with vitiligo or psoriasis who received narrowband ultraviolet B phototherapy (308 nm/311 nm): A retrospective review of 3730 patients. Chia BKY, Yew YW, Zhao X, Chong WS, Thng TGS. Photodermatol Photoimmunol Photomed; 2023 Jul; 39(4):343-350. PubMed ID: 36345565 [Abstract] [Full Text] [Related]
11. Incidence and profile of skin cancers in patients following ultraviolet phototherapy without psoralens: A retrospective cohort study. Wang E, Ahad T, Liu YA, Lee TK, Lui H, Crawford RI, Kalia S. J Am Acad Dermatol; 2024 Apr; 90(4):759-766. PubMed ID: 38070541 [Abstract] [Full Text] [Related]
12. The photocarcinogenic risk of narrowband UVB (TL-01) phototherapy: early follow-up data. Man I, Crombie IK, Dawe RS, Ibbotson SH, Ferguson J. Br J Dermatol; 2005 Apr; 152(4):755-7. PubMed ID: 15840109 [Abstract] [Full Text] [Related]
13. [Narrow-band UVB therapy in psoriasis vulgaris: good practice guideline and recommendations of the French Society of Photodermatology]. Beani JC, Jeanmougin M. Ann Dermatol Venereol; 2010 Jan; 137(1):21-31. PubMed ID: 20110064 [Abstract] [Full Text] [Related]
14. Serum 5-S-cysteinyldopa levels in patients with psoriasis undergoing narrowband ultraviolet B phototherapy. Kikuchi K, Wakamatsu K, Tada Y, Komine M, Ito S, Tamaki K. Clin Exp Dermatol; 2008 Nov; 33(6):750-3. PubMed ID: 18954414 [Abstract] [Full Text] [Related]
15. Predictors of adherence to Narrowband ultraviolet B first-month treatment dosage plan. Pavlotsky F, Alkhazov A, Barzilai A, Scope A. Isr Med Assoc J; 2022 Dec; 25(12):820-823. PubMed ID: 36573776 [Abstract] [Full Text] [Related]
16. Photocarcinogenic Risk Associated With Narrowband UV-B Phototherapy: An Epidemiologic Study in a Tertiary Care Hospital. Ortiz-Salvador JM, Ferrer DS, Saneleuterio-Temporal M, Victoria Martínez AM, Ferriols AP, Vilata Corell JJ, Alegre de Miquel V. Actas Dermosifiliogr (Engl Ed); 2018 May; 109(4):340-345. PubMed ID: 29463381 [Abstract] [Full Text] [Related]
17. No evidence for increased skin cancer risk in Koreans with skin phototypes III-V treated with narrowband UVB phototherapy. Jo SJ, Kwon HH, Choi MR, Youn JI. Acta Derm Venereol; 2011 Jan; 91(1):40-3. PubMed ID: 21031281 [Abstract] [Full Text] [Related]
18. Synergism between narrowband ultraviolet B phototherapy and etanercept for the treatment of plaque-type psoriasis. Calzavara-Pinton PG, Sala R, Arisi M, Rossi MT, Venturini M, Ortel B. Br J Dermatol; 2013 Jul; 169(1):130-6. PubMed ID: 23834117 [Abstract] [Full Text] [Related]
19. Methotrexate did not add skin cancer risk in patients with psoriasis receiving narrowband ultraviolet B phototherapy: a nationwide retrospective cohort study. Chao CH, Wu CY, Chou FL, Chen YJ. Clin Exp Dermatol; 2024 Apr 23; 49(5):459-465. PubMed ID: 38056487 [Abstract] [Full Text] [Related]
20. Risk of Skin Cancer in Patients with Psoriasis: Single-Center Retrospective Study Comparing Anti-TNFα and Phototherapy. Trovato E, Dragotto M, Capalbo E, Cartocci A, Rubegni P, Calabrese L. J Clin Med; 2024 Apr 23; 13(9):. PubMed ID: 38730981 [Abstract] [Full Text] [Related] Page: [Next] [New Search]